Key Highlights
Listing timeline: Early 2026 on Bursa Malaysia
Structure: IPO of up to 1.97B shares (new + existing)
Dividend-in-specie: 1 Sunway Healthcare Holdings (SHH) share for every 10 Sunway shares
Ownership post-listing: Sunway to retain 69.5% stake in SHH
Scale: 5 hospitals, 1,662 beds; targeted capacity of 3,400 beds by 2032
Corporate Restructuring & Shareholder Benefit
Sunway Bhd (KL:SUNWAY) has unveiled long-awaited plans to list its healthcare subsidiary, Sunway Healthcare Holdings Bhd (SHH), by early 2026. Ahead of the IPO, SHH will execute a 1-for-9 share split, increasing its share base from 1.2B to 10.9B, without altering its RM2.2B valuation.
SunCity, Sunway’s wholly-owned unit, will distribute SHH shares to Sunway as a special dividend, which will then be passed on to Sunway shareholders. Each shareholder will receive 1 SHH share for every 10 Sunway shares held, effectively giving investors direct exposure to the healthcare business.
IPO Structure & Use of Proceeds
Offer Size: Up to 1.97B shares
575M new shares (public issue)
1.4B existing shares (offer for sale)
Stake Offered: Up to 17.2% of SHH
Advisers: Maybank Investment Bank & AmInvestment Bank
Proceeds allocation:
Sunway: Pare down borrowings, fund working capital, cover listing costs
SHH: Expand existing hospitals, build new facilities, redeem Islamic MTNs, and defray IPO expenses
Strategic Rationale
Sunway aims to unlock shareholder value while retaining majority control. Post-listing, Sunway will hold 69.5% of SHH, ensuring continued participation in its earnings.
The IPO will also:
Provide SHH direct access to capital markets
Enhance financial flexibility for hospital expansion
Boost visibility as a leading private healthcare provider in Southeast Asia
Growth & Expansion Outlook
Current footprint: 5 hospitals with 1,662 licensed beds (Subang Jaya, Cheras, Penang, Damansara, Ipoh)
Pipeline: New hospitals in Seremban, Iskandar Puteri, Putrajaya + fertility centre in Kota Bharu
Target: Over 3,400 beds by 2032
SHH also operates fertility services, ambulatory care, senior living, home care, and traditional medicine, strengthening its integrated healthcare model.
Financial Performance
FY2024 Revenue: RM1.85B (+27% YoY)
FY2024 Net Profit: RM257.5M (+42% YoY)
Adjusted EBITDA: RM458.5M (+20% YoY)
This strong earnings trajectory underscores SHH’s scalability and margin resilience.
Sector Context
The listing comes amid heightened investor focus on Malaysia’s healthcare sector as rising medical costs push up insurance premiums and prompt regulatory scrutiny. Recent deals highlight consolidation trends:
IHH Healthcare Bhd’s acquisition of Island Hospital
Sime Darby & Ramsay Health Care’s RM5.7B divestment of Ramsay Sime Darby Health Care to Columbia Asia
Sunway’s move positions SHH as a regional growth story, backed by robust demand for private healthcare.
Market Reaction
Sunway share price: Down 0.4% to RM4.92 (market cap RM30.85B) at midday Friday
YTD performance: +4.02%
While the stock eased slightly on announcement, analysts view the healthcare spin-off as a value-unlocking catalyst over the medium term.
Investment Take
Sunway’s healthcare IPO provides:
Direct exposure to one of Southeast Asia’s fastest-growing private hospital networks
Structural growth from bed expansion and diversification of healthcare services
Defensive earnings profile amid rising demand for quality private healthcare
With regional comparables trading at premium multiples, SHH’s IPO could re-rate Sunway’s healthcare assets and provide investors a new avenue for growth exposure.
Comments
Post a Comment